Literature DB >> 17396994

The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania.

Saidi H Kapiga1, Noel E Sam, Heejung Bang, Quanhong Ni, Trong T H Ao, Ireen Kiwelu, Sarah Chiduo, Uzodinma Ndibe, George Seage, Paul Coplan, John Shao, Zeda F Rosenberg, Max Essex.   

Abstract

BACKGROUND: We examined the role of herpes simplex virus type 2 (HSV-2) and other genital infections on human immunodeficiency virus type 1 (HIV-1) incidence in a cohort study conducted between 2002 and 2005 among female bar/hotel workers in Moshi, Tanzania.
METHODS: At baseline and every 3 months thereafter, participants were interviewed, and blood and genital samples were collected. Predictors of HIV-1 incidence were evaluated using a Cox proportional hazards regression model.
RESULTS: Of 845 women who were HIV-1 seronegative at baseline, 689 (81.5%) were monitored in the study for a total of 698.6 person-years at risk (PYARs). The overall HIV-1 incidence was 4.6/100 PYARs (95% confidence interval [CI], 3.0-6.2/100 PYARs), and condom use was very low. After adjustment for other risk factors, the risk of HIV-1 was increased among women with HSV-2 at baseline (hazard ratio [HR], 4.3 [95% CI, 1.5-12.4]) and in those who acquired HSV-2 during the study period (HR, 5.5 [95% CI, 1.2-25.4]). Other independent predictors of HIV-1 were baseline chlamydial infection (HR, 5.2), bacterial vaginosis (HR, 2.1), and the occurrence of genital ulcers (HR, 2.7).
CONCLUSION: HSV-2 and other genital infections were the most important risk factors for HIV-1. Control of these infections could help to reduce HIV-1 incidence in this population.

Entities:  

Mesh:

Year:  2007        PMID: 17396994     DOI: 10.1086/513566

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.

Authors:  José A Fernández-Romero; Ciby J Abraham; Aixa Rodriguez; Larisa Kizima; Ninochka Jean-Pierre; Radhika Menon; Othell Begay; Samantha Seidor; Brian E Ford; Pedro I Gil; Jennifer Peters; David Katz; Melissa Robbiani; Thomas M Zydowsky
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Salaam Semaan
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

3.  Association of age at first sex with HIV-1, HSV-2, and other sexual transmitted infections among women in northern Tanzania.

Authors:  Musie Ghebremichael; Ulla Larsen; Elijah Paintsil
Journal:  Sex Transm Dis       Date:  2009-09       Impact factor: 2.830

Review 4.  Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention.

Authors:  Aaron Ar Tobian; Thomas C Quinn
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

5.  Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa.

Authors:  Joelle Sobngwi-Tambekou; Dirk Taljaard; Pascale Lissouba; Kevin Zarca; Adrian Puren; Emmanuel Lagarde; Bertram Auvert
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

6.  Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.

Authors:  Amanda Kwant-Mitchell; Ali A Ashkar; Kenneth L Rosenthal
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

7.  The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth.

Authors:  Marshall W Munjoma; Edith N Kurewa; Munyaradzi P Mapingure; Grace V Mashavave; Mike Z Chirenje; Simbarashe Rusakaniko; Akhtar Hussain; Babill Stray-Pedersen
Journal:  BMC Womens Health       Date:  2010-01-12       Impact factor: 2.809

8.  A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy.

Authors:  Federica Crostarosa; Meropi Aravantinou; Onome J Akpogheneta; Edith Jasny; Andrew Shaw; Jessica Kenney; Michael Piatak; Jeffrey D Lifson; Aaron Teitelbaum; Lieyu Hu; Anne Chudolij; Thomas M Zydowsky; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

Review 9.  Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis.

Authors:  Adriane Martin Hilber; Suzanna C Francis; Matthew Chersich; Pippa Scott; Shelagh Redmond; Nicole Bender; Paolo Miotti; Marleen Temmerman; Nicola Low
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

10.  Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors.

Authors:  K Baisley; J Changalucha; H A Weiss; K Mugeye; D Everett; I Hambleton; P Hay; D Ross; C Tanton; T Chirwa; R Hayes; D Watson-Jones
Journal:  Sex Transm Infect       Date:  2009-05-26       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.